1. Home
  2. GFL vs NBIX Comparison

GFL vs NBIX Comparison

Compare GFL & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GFL Environmental Inc. Subordinate voting shares no par value

GFL

GFL Environmental Inc. Subordinate voting shares no par value

N/A

Current Price

$42.57

Market Cap

18.7B

Sector

N/A

ML Signal

N/A

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

N/A

Current Price

$146.78

Market Cap

15.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GFL
NBIX
Founded
2007
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.7B
15.5B
IPO Year
2019
1996

Fundamental Metrics

Financial Performance
Metric
GFL
NBIX
Price
$42.57
$146.78
Analyst Decision
Buy
Strong Buy
Analyst Count
10
22
Target Price
$55.22
$180.91
AVG Volume (30 Days)
2.4M
927.8K
Earning Date
04-29-2026
05-05-2026
Dividend Yield
0.16%
N/A
EPS Growth
N/A
41.95
EPS
N/A
3.30
Revenue
N/A
$161,626,000.00
Revenue This Year
$8.18
$24.73
Revenue Next Year
$7.20
$13.14
P/E Ratio
$5.95
$44.30
Revenue Growth
N/A
977.51
52 Week Low
$33.33
$122.14
52 Week High
$48.07
$186.12

Technical Indicators

Market Signals
Indicator
GFL
NBIX
Relative Strength Index (RSI) 50.58 31.77
Support Level $41.08 $125.85
Resistance Level $42.26 $161.41
Average True Range (ATR) 1.23 4.31
MACD -0.11 -0.66
Stochastic Oscillator 29.13 6.72

Price Performance

Historical Comparison
GFL
NBIX

About GFL GFL Environmental Inc. Subordinate voting shares no par value

GFL Environmental Inc is an environmental services company. Its offerings include non-hazardous solid waste management, infrastructure, soil remediation, and liquid waste management services. Its solid waste management business line, which generates the majority of the revenue, consists of the collection, transportation, transfer, recycling, and disposal of non-hazardous solid waste. Its Environmental Services business line includes liquid waste and soil remediation. The company's geographical segments are Canada and the United States. The company derives the majority of its revenue from the United States.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: